Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dimos-Dimitrios D. Mitsikostas
Correction To: Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis
CNS Drugs
Psychiatry
Mental Health
Neurology
Pharmacology
Related publications
No Evidence of Disease Activity: Indirect Comparisons of Oral Therapies for the Treatment of Relapsing–Remitting Multiple Sclerosis
Advances in Therapy
Medicine
Pharmacology
Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis
Neuropsychiatric Disease and Treatment
Psychiatry
Mental Health
Biological Psychiatry
Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Archives of Neurology
Pnd105 - Multiple Sclerosis: The Map of Patient Access to Disease Modifying Treatments in Europe
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Characteristics of Pediatric Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cerebrovascular Reactivity and Disease Activity in Relapsing-Remitting Multiple Sclerosis
Advances in Clinical and Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Disease-Modifying Treatments for Alzheimer’s Disease
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
Multiple Sclerosis Disease-Modifying Therapy and Pregnancy
Multiple Sclerosis
Neurology
Pnd120 - Treatment Decisions About First-Line Disease-Modifying Treatments (Dmts) in Relapsing Remitting Multiple Sclerosis: A Systematic Review of Patient Needs and Preferences
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
